Christopher R Britt, the Chief Executive Officer of $CHYM, sold 50,000 shares of the company on 01-09-2026 for an estimated $1,402,825. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $CHYM stock.
$CHYM Insider Trading Activity
$CHYM insiders have traded $CHYM stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $CHYM stock by insiders over the last 6 months:
- JAMES FEUILLE has made 0 purchases and 3 sales selling 183,397 shares for an estimated $4,957,755.
- AMINE ASMEROM (Chief Accounting Officer) has made 0 purchases and 2 sales selling 84,589 shares for an estimated $1,704,972.
- CHRISTOPHER R BRITT (Chief Executive Officer) sold 50,000 shares for an estimated $1,402,825
- ADAM B FRANKEL (General Counsel) has made 0 purchases and 6 sales selling 13,142 shares for an estimated $333,745.
- MATTHEW S NEWCOMB (Chief Financial Officer) sold 10,000 shares for an estimated $280,109
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CHYM Hedge Fund Activity
We have seen 92 institutional investors add shares of $CHYM stock to their portfolio, and 75 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS added 3,258,179 shares (+90.0%) to their portfolio in Q3 2025, for an estimated $65,717,470
- DAVIS SELECTED ADVISERS added 2,399,166 shares (+inf%) to their portfolio in Q3 2025, for an estimated $48,391,178
- LUNATE CAPITAL LTD added 1,809,763 shares (+inf%) to their portfolio in Q3 2025, for an estimated $36,502,919
- CITADEL ADVISORS LLC added 1,749,604 shares (+276.3%) to their portfolio in Q3 2025, for an estimated $35,289,512
- GREENHOUSE FUNDS LLLP added 1,595,078 shares (+210.5%) to their portfolio in Q3 2025, for an estimated $32,172,723
- MARSHALL WACE, LLP added 1,520,047 shares (+577.3%) to their portfolio in Q3 2025, for an estimated $30,659,347
- BLACKROCK, INC. removed 1,245,337 shares (-35.6%) from their portfolio in Q3 2025, for an estimated $25,118,447
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CHYM Revenue
$CHYM had revenues of $543.5M in Q2 2025. This is an increase of 41.46% from the same period in the prior year.
You can track CHYM financials on Quiver Quantitative's CHYM stock page.
$CHYM Analyst Ratings
Wall Street analysts have issued reports on $CHYM in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 01/06/2026
- B. Riley Securities issued a "Buy" rating on 12/11/2025
- JP Morgan issued a "Overweight" rating on 11/06/2025
- Keefe, Bruyette & Woods issued a "Outperform" rating on 10/01/2025
- Canaccord Genuity issued a "Buy" rating on 08/11/2025
To track analyst ratings and price targets for $CHYM, check out Quiver Quantitative's $CHYM forecast page.
$CHYM Price Targets
Multiple analysts have issued price targets for $CHYM recently. We have seen 8 analysts offer price targets for $CHYM in the last 6 months, with a median target of $32.0.
Here are some recent targets:
- Will Nance from Goldman Sachs set a target price of $30.0 on 01/06/2026
- Hal Goetsch from B. Riley Securities set a target price of $35.0 on 12/11/2025
- Patrick Moley from Piper Sandler set a target price of $30.0 on 11/06/2025
- Tien-Tsin Huang from JP Morgan set a target price of $34.0 on 11/06/2025
- Timothy Chiodo from UBS set a target price of $24.0 on 11/06/2025
- Trevor Williams from Jefferies set a target price of $17.0 on 11/03/2025
- Joseph Vafi from Canaccord Genuity set a target price of $40.0 on 10/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
